Cu^II Binding Properties of N-Truncated Aβ Peptides: In Search of Biological Function

Area of Science:

• Neuroscience
• Biochemistry
• Metalloprotein chemistry

Background:

• Alzheimer's Disease (AD) is a progressive dementia with increasing prevalence.
• Current AD drug development faces challenges, potentially due to unidentified disease origins.
• Amyloid cascade, metal ions, and reactive oxygen species (ROS) are implicated in AD pathogenesis.

Purpose of the Study:

• To investigate the copper(II) (Cu(II)) binding properties of Aβ₄-, a prevalent N-truncated Aβ peptide.
• To propose physiological roles for Aβ₄- peptides based on their copper-binding characteristics.
• To explore the implications of Cu(II)Aβ₄- interactions in the synaptic cleft for AD.

Main Methods:

• Characterization of Cu(II) binding by Aβ₄- peptides.
• Comparison of copper uptake and complex stability with Aβ₁- peptides.
• Assessment of the reactivity of Cu(II)Aβ₄- complexes with biomolecules.

Main Results:

• Aβ₄- peptides exhibit rapid copper uptake and form highly stable Cu(II) complexes.
• These complexes are redox unreactive and resistant to copper exchange.
• Cu(II)Aβ₄- interactions in the synaptic cleft were analyzed in the context of neurotransmission.

Conclusions:

• Aβ₄- peptides may play a physiological role in quenching Cu(II) toxicity within the brain.
• The formation of stable Cu(II) complexes by Aβ₄- could be crucial for maintaining neurotransmission.
• These findings suggest a potential neuroprotective function for N-truncated Aβ peptides in Alzheimer's Disease.